ROCHE I revenue for the last year amounted to 60.49 B CHF, the most of which — 48.04 B CHF — came from its highest performing source at the moment, Pharmaceuticals, the year earlier bringing 46.28 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought ROCHE I 30.17 B CHF, and the year before that — 28.35 B CHF.